Skip to content
The BCI Briefing

FrontierWhat is becoming possible?

The BCI Frontier

A map of what brain-computer interfaces can do, arranged by how firmly each capability is established: demonstrated in people at the centre, emerging possibilities at the rim. Choose a domain to see what is possible today, the latest milestone, who is working on it and what has to happen next.

Today
Fig. 01 — The BCI FrontierSelect a domain. Dots are individual capabilities; hover for detail.
  • Demonstrated today
  • Early clinical
  • Research frontier
  • Emerging possibility

Zones are qualitative editorial judgements. A capability sits in a zone, not at a point, and the map implies no ranking between domains.

Frontier domain

Speech & Communication

What is possible today

Research participants who cannot speak have communicated in full sentences, from large vocabularies, through implanted BCIs. One participant used his system for more than 248 hours of conversation at about 97% word accuracy.

Latest important milestone14 Sep 2026

A single surface implant decoded speech and upper-body gestures at the same time in three participants.

Brosler SC et al., Nature Neuroscience

Capabilities by zone

Approaches
Intracortical arrays in ventral precentral gyrus · High-density ECoG over sensorimotor cortex · Phoneme decoding with language models · Direct brain-to-voice synthesis
Clinical maturity
Early feasibility. Strong peer-reviewed results in individual participants; the first commercial speech studies began in 2025–2026.
Labs
University of California, DavisStanford UniversityUniversity of California, San FranciscoJohns Hopkins UniversityUMC Utrecht
On the calendar
BCI Meeting 2027
Patent themes
165 patent families concern speech decoding. Filing shows where protection is sought, not that a capability works. The patent landscape

What needs to happen next

  1. 01Fully implanted, wireless systems matching the accuracy of wired research rigs
  2. 02Peer-reviewed results from commercial feasibility studies
  3. 03Performance that holds as conditions such as ALS progress
  4. 04Decoders that transfer between people without hours of calibration

Speech is the application closest to clinical usefulness: accuracy is already at a dependable level in individual participants. The next two years are about engineering and evidence — implantable hardware, more participants, longer follow-up — more than about new science.

Unresolved and emerging

Open Frontiers

The questions that decide what happens next. Each is read across six dimensions, so that scientific momentum, clinical need and capital can be seen side by side.

    • Early human evidence
    • High technical uncertainty

    Published human data extend to years for a few participants and designs. Each new electrode technology has to earn its own record.

    Start fromPlug-and-play control of a brain–computer interface through neural map stabilizationSampling representational plasticity of simple imagined movements across days enables long-term neuroprosthetic controlIntracortical

    Scientific momentum
    moderate
    Clinical need
    high
    Human evidence
    moderate
    Technical maturity
    low
    Competition density
    moderate
    Capital intensity
    high

Bars show low, moderate or high on each dimension. These are BCI Briefing judgements intended to make the landscape legible. They do not rank opportunities and are not investment advice.

The outlook

What happens next?

Four horizons, from now to beyond five years. Observed trajectories are on the left; plausible milestones, necessary breakthroughs and key uncertainties follow to the right.

Now

1–2 years

  • Plausible next milestone

    A pivotal trial of a permanently implanted BCI is registered.

    Synchron

  • Plausible next milestone

    Peer-reviewed results appear from commercial early feasibility studies.

    COMMANDConnect-One

  • Necessary breakthrough

    High-performance decoders that stay calibrated for months without supervised retraining.

    FALCON benchmark

  • Key uncertainty

    Whether signal quality from newer electrode designs holds beyond the first years in people.

3–5 years

  • Plausible next milestone

    A first marketing authorisation for an implanted communication or control BCI in a major market.

  • Necessary breakthrough

    Fully implanted, wireless, high-channel systems with multi-year reliability data.

  • Key uncertainty

    Reimbursement, surgical capacity and long-term device support — the factors that decided the pace of cochlear implant adoption.

    Hearing

Beyond

  • Plausible next milestone

    Bidirectional systems that combine movement and touch in everyday use.

    Somatosensory Feedback

  • Necessary breakthrough

    A non-implanted signal with bandwidth approaching implanted systems. There is no human evidence for this yet.

    Merge Labs

  • Key uncertainty

    How society chooses to govern interfaces for people without a medical need.

Only the first column describes what has happened. Everything to its right is a forward-looking judgement by The BCI Briefing as of 3 Oct 2026, and should be read as uncertain.